TY - JOUR AU - Cox, R. J. AU - Brokstad, K. A. AU - Ogra, P. PY - 2004 DA - 2004// TI - Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines JO - Scand J Immunol VL - 59 UR - https://doi.org/10.1111/j.0300-9475.2004.01382.x DO - 10.1111/j.0300-9475.2004.01382.x ID - Cox2004 ER - TY - STD TI - World Health Organization. Influenza virus infections in humans. 2014. Available at: http://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/influenza_virus_infections_humans_feb14.pdf. Accessed 13 Apr 2015. UR - http://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/influenza_virus_infections_humans_feb14.pdf ID - ref2 ER - TY - STD TI - World Health Organization. Influenza (Seasonal) Fact sheet Number 211 March 2014. ID - ref3 ER - TY - JOUR AU - Rothberg, M. B. AU - Haessler, S. D. AU - Brown, R. B. PY - 2008 DA - 2008// TI - Complications of viral influenza JO - Am J Med VL - 121 UR - https://doi.org/10.1016/j.amjmed.2007.10.040 DO - 10.1016/j.amjmed.2007.10.040 ID - Rothberg2008 ER - TY - STD TI - European Commission. Proposal for a Council Recommendation on seasonal influenza vaccination. 2009. Available at: http://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf. Accessed 13 April 2015. UR - http://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf ID - ref5 ER - TY - JOUR AU - Levy, E. PY - 1996 DA - 1996// TI - French economic evaluations of influenza and influenza vaccination JO - PharmacoEconomics VL - 9 UR - https://doi.org/10.2165/00019053-199600093-00014 DO - 10.2165/00019053-199600093-00014 ID - Levy1996 ER - TY - JOUR AU - Lee, K. AU - Seong, B. L. PY - 1999 DA - 1999// TI - Current status for influenza control JO - Biotechnol Bioprocess Eng VL - 4 UR - https://doi.org/10.1007/BF02931921 DO - 10.1007/BF02931921 ID - Lee1999 ER - TY - JOUR AU - Skehel, J. J. AU - Wiley, D. C. PY - 2000 DA - 2000// TI - Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin JO - Annu Rev Biochem VL - 69 UR - https://doi.org/10.1146/annurev.biochem.69.1.531 DO - 10.1146/annurev.biochem.69.1.531 ID - Skehel2000 ER - TY - JOUR AU - Shtyrya, Y. A. AU - Mochalova, L. V. AU - Bovin, N. V. PY - 2009 DA - 2009// TI - Influenza virus neuraminidase: structure and function JO - Acta Nat VL - 1 ID - Shtyrya2009 ER - TY - JOUR AU - Verhoeyen, M. AU - Fang, R. AU - Jou, W. M. AU - Devos, R. AU - Huylebroeck, D. AU - Saman, E. AU - Fiers, W. PY - 1980 DA - 1980// TI - Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75 JO - Nature VL - 286 UR - https://doi.org/10.1038/286771a0 DO - 10.1038/286771a0 ID - Verhoeyen1980 ER - TY - STD TI - World Health Organization. Questions and answers. Vaccine effectiveness estimates for seasonal influenza vaccines. 2015. Available at: http://www.who.int/influenza/vaccines/virus/recommendations/201502_qanda_vaccineeffectiveness.pdf. Accessed 13 April 2015. UR - http://www.who.int/influenza/vaccines/virus/recommendations/201502_qanda_vaccineeffectiveness.pdf ID - ref11 ER - TY - JOUR AU - Berlanda Scorza, F. AU - Tsvetnitsky, V. AU - Donnelly, J. J. PY - 2016 DA - 2016// TI - Universal influenza vaccines: Shifting to better vaccines JO - Vaccine VL - 34 UR - https://doi.org/10.1016/j.vaccine.2016.03.085 DO - 10.1016/j.vaccine.2016.03.085 ID - Berlanda Scorza2016 ER - TY - JOUR AU - Pleguezuelos, O. AU - Robinson, S. AU - Stoloff, G. A. AU - Caparros-Wanderly, W. PY - 2012 DA - 2012// TI - Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomized, placebo-controlled Phase I trial JO - Vaccine VL - 30 UR - https://doi.org/10.1016/j.vaccine.2012.04.089 DO - 10.1016/j.vaccine.2012.04.089 ID - Pleguezuelos2012 ER - TY - JOUR AU - Reber, A. AU - Katz, J. PY - 2013 DA - 2013// TI - Immunological assessment of influenza vaccines and immune correlates of protection JO - Expert Rev Vaccines VL - 12 UR - https://doi.org/10.1586/erv.13.35 DO - 10.1586/erv.13.35 ID - Reber2013 ER - TY - JOUR AU - Sridhar, S. AU - Begom, S. AU - Bermingham, A. AU - Hoschler, K. AU - Adamson, W. AU - Carman, W. PY - 2013 DA - 2013// TI - Cellular immune correlates of protection against symptomatic pandemic influenza JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3350 DO - 10.1038/nm.3350 ID - Sridhar2013 ER - TY - JOUR AU - Altman, D. G. AU - Bland, J. M. PY - 1999 DA - 1999// TI - How to randomise JO - BMJ VL - 319 UR - https://doi.org/10.1136/bmj.319.7211.703 DO - 10.1136/bmj.319.7211.703 ID - Altman1999 ER - TY - STD TI - ALEA. Release version 15.1. Available at: https://www.tenalea.com/nkiavl/ALEA/Login.aspx. UR - https://www.tenalea.com/nkiavl/ALEA/Login.aspx ID - ref17 ER - TY - JOUR AU - Schulz, K. F. AU - Altman, D. G. AU - Moher, D. PY - 2010 DA - 2010// TI - CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials JO - PLoS Med VL - 7 UR - https://doi.org/10.1371/journal.pmed.1000251 DO - 10.1371/journal.pmed.1000251 ID - Schulz2010 ER - TY - JOUR AU - Wilkinson, T. M. AU - Li, C. K. AU - Chui, C. S. AU - Huang, A. K. AU - Perkins, M. AU - Liebner, J. C. PY - 2012 DA - 2012// TI - Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2612 DO - 10.1038/nm.2612 ID - Wilkinson2012 ER - TY - JOUR AU - Horton, H. AU - Thomas, E. P. AU - Stucky, J. A. AU - Frank, I. AU - Moodie, Z. AU - Huang, Y. PY - 2007 DA - 2007// TI - Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination JO - J Immunol Methods VL - 323 UR - https://doi.org/10.1016/j.jim.2007.03.002 DO - 10.1016/j.jim.2007.03.002 ID - Horton2007 ER - TY - STD TI - Salk HM, Haralambieva IH, Ovsyannikova IG, Goergen KM, Poland GA. Granzyme B ELISPOT assay to measure influenza-specific cellular immunity. J Immunol Methods 2013;398-399:44-50. ID - ref21 ER - TY - JOUR AU - Lindemann, M. AU - Witzke, O. AU - Lutkes, P. AU - Fiedler, M. AU - Kreuzfelder, E. AU - Philipp, T. PY - 2006 DA - 2006// TI - ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients JO - Clin Immunol VL - 120 UR - https://doi.org/10.1016/j.clim.2006.03.002 DO - 10.1016/j.clim.2006.03.002 ID - Lindemann2006 ER - TY - JOUR AU - Jegaskanda, S. AU - Job, E. R. AU - Kramski, M. AU - Laurie, K. AU - Isitman, G. AU - Rose, R. PY - 2013 DA - 2013// TI - Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies JO - J Immunol VL - 190 UR - https://doi.org/10.4049/jimmunol.1201574 DO - 10.4049/jimmunol.1201574 ID - Jegaskanda2013 ER - TY - JOUR AU - Pleguezuelos, O. AU - Robinson, S. AU - Fernandez, A. AU - Stoloff, G. A. AU - Mann, A. AU - Gilbert, A. PY - 2015 DA - 2015// TI - A Synthetic Influenza Virus Vaccine Induces a Cellular Immune Response That Correlates with Reduction in Symptomatology and Virus Shedding in a Randomized Phase Ib Live-Virus Challenge in Humans JO - Clin Vaccine Immunol VL - 22 UR - https://doi.org/10.1128/CVI.00098-15 DO - 10.1128/CVI.00098-15 ID - Pleguezuelos2015 ER - TY - JOUR AU - Wilson-Welder, J. H. AU - Torres, M. P. AU - Kipper, M. J. AU - Mallapragada, S. K. AU - Wannemuehler, M. J. AU - Narasimhan, B. PY - 2009 DA - 2009// TI - Vaccine adjuvants: current challenges and future approaches JO - J Pharm Sci VL - 98 UR - https://doi.org/10.1002/jps.21523 DO - 10.1002/jps.21523 ID - Wilson-Welder2009 ER - TY - JOUR AU - Aucouturier, J. AU - Dupuis, L. AU - Deville, S. AU - Ascarateil, S. AU - Ganne, V. PY - 2002 DA - 2002// TI - Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines JO - Expert Rev Vaccines VL - 1 UR - https://doi.org/10.1586/14760584.1.1.111 DO - 10.1586/14760584.1.1.111 ID - Aucouturier2002 ER - TY - JOUR AU - Aucouturier, J. AU - Dupuis, L. AU - Ganne, V. PY - 2001 DA - 2001// TI - Adjuvants designed for veterinary and human vaccines JO - Vaccine VL - 19 UR - https://doi.org/10.1016/S0264-410X(00)00498-9 DO - 10.1016/S0264-410X(00)00498-9 ID - Aucouturier2001 ER - TY - JOUR AU - Doorn, E. AU - Liu, H. AU - Huckriede, A. AU - Hak, E. PY - 2016 DA - 2016// TI - Safety and tolerability evaluation of the use of Montanide ISA51 as vaccine adjuvant: a systematic review JO - Hum Vaccin Immunother VL - 12 UR - https://doi.org/10.1080/21645515.2015.1071455 DO - 10.1080/21645515.2015.1071455 ID - Doorn2016 ER - TY - JOUR AU - Ascarateil, S. AU - Puget, A. AU - Koziol, M. PY - 2015 DA - 2015// TI - Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines JO - J Immunother Cancer VL - 3 UR - https://doi.org/10.1186/2051-1426-3-S2-P428 DO - 10.1186/2051-1426-3-S2-P428 ID - Ascarateil2015 ER -